Ann: Prima Raises $20 million in Share Purchase P, page-8

re: Ann: Prima Raises $20 million in Share Pu... Not really speculative at all.
If safety can be proved up of a product/technology and there is an unmet need then FDA can fast track it.

Read this from the FDA website, it explains it better than I can:

"Fast Track, Accelerated Approval and Priority Review.
Accelerating Availability of New Drugs for Patients with Serious Diseases"

http://www.fda.gov/forconsumers/byaudience/forpatientadvocates/speedingaccesstoimportantnewtherapies/ucm128291.htm


CVac meets the FDA criteria in the link with respect to treatment for Ovarian cancer.